There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Pandemic Anti-Monopoly Act of 2020

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To prohibit certain transactions during the coronavirus disease 2019 (COVID-19) pandemic.


Actions Overview (1)

Date Actions Overview
05/22/2020Introduced in House

All Actions (2)

Date All Actions
05/22/2020Referred to the House Committee on the Judiciary.
Action By: House of Representatives
05/22/2020Introduced in House
Action By: House of Representatives

Cosponsors (2)

* = Original cosponsor
CosponsorDate Cosponsored
Rep. Garcia, Jesus G. "Chuy" [D-IL-4]* 05/22/2020
Rep. Omar, Ilhan [D-MN-5]* 05/22/2020

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Judiciary05/22/2020 Referred to

As of 07/07/2020 no related bill information has been received for H.R.6989 - Pandemic Anti-Monopoly Act of 2020


Latest Summary (1)

There is one summary for H.R.6989. View summaries

Shown Here:
Introduced in House (05/22/2020)

Pandemic Anti-Monopoly Act of 2020

This bill places a moratorium on certain mergers and acquisitions during the COVID-19 (i.e., coronavirus disease 2019) pandemic.

Specifically, the bill prohibits certain transactions such as acquisitions (1) by firms with over $100 million in revenue; (2) by financial institutions or equity funds with over $100 million in capitalization; and (3) involving firms with exclusive patents pertaining to COVID-19 pandemic-related production, manufacturing, distribution, or infrastructure. However, a waiver may be granted if the participating firms demonstrate that the transaction will advance critical national security, economic, or public health interests during the emergency.

Further, the bill establishes a legal presumption against a transaction that may pose a risk to the government's ability to respond to the national emergency declared due to COVID-19.